Biotech update from Bret Jensen.
http://investorinthefamily.com/
- Outperforming market in 2017 after 18 month bear
- Big uptick in M&A in Jan
-
- Feb and Mar have been fairly flat
- Lots of resistance technically
-
- Need an uptick in MA or earnings to break through
- Expect the uptick to happen in MA
- Watch Trump’s actions and not words
-
- Has appointed 2 free market minded people (FDA,
- Proposed to double fees for drug approval
- Watching repeal and replace of ACA
-
- Needs to happen before tax and regulatory reform
- Expect the repeal to happen by April or May
- Ocular Therapeutix (OCUL)
-
- Trigger event in July, new product for cataract surgery
- Insider buying
- Omerisk (OMER)
-
- OMS721
- Priced at just over $10 w PTs in the $30
- Next trigger event in few years